Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Drug Prices
Pharma
FTC targets Novo's Ozempic among 300-plus 'junk' patents
Similar to its first round of challenge against allegedly improper listings in the FDA's Orange Book, the FTC is again targeting drug-device combos.
Angus Liu
May 1, 2024 7:30am
J&J, BMS set to appeal losses in IRA drug pricing lawsuits
Apr 30, 2024 11:48am
Novo Nordisk grilled by Sanders over steep GLP-1 pricing
Apr 25, 2024 2:58pm
Novo Nordisk attracts lawmakers' ire for Levemir insulin pull
Apr 18, 2024 10:40am
DOJ sues Regeneron for under-reporting Eylea price to Medicare
Apr 11, 2024 11:12am
HHS responds to Big Pharma's IRA counteroffers
Apr 3, 2024 11:18am